Therefore, dietary strategies that modulate metabolic conditions in the TME have the potential to influence anti-tumour immune responses—either in isolation or in combination with ICI treatments—by metabolic reprogramming of CD8+ T cell function. Here, CD8A is linked to neoplasm.